February 21, 2007 – InSightec’s ExAblate 2000, a Magnetic Resonance Imaging (MRI) focused ultrasound device that treats uterine fibroid tumors, is now allowing most patients to find relief within three months of treatment and to return to work within days.
The ExAblate 2000 uses a combination of ultrasound waves and MRIs to image, treat and ablate soft tissue. Treatment typically takes about three or four hours.
June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...
June 18, 2026 
June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...
June 12, 2026 
May 27, 2026 — Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE ...
June 03, 2026 
May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...
May 22, 2026 
May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...
May 19, 2026 
May 7, 2026 — Openwater, an open-source medical technology company has announced a collaboration with the Sharma Lab, a ...
May 07, 2026 
April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...
April 28, 2026 
April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...
April 23, 2026 
April 20, 2026 — Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in ...
April 23, 2026 
April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...
April 09, 2026 